CERo Therapeutics Holdings Inc. - Warrants (13/02/2029)
CEROW
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.43K
Close$
$1.45
131718.2% upside
Current Fair Value
131718.2% upsideUndervalued by 131718.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $46,426.00 |
|---|---|
| Enterprise Value | $-212,718.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-22.58 |
| Beta | 1.37 |
| Outstanding Shares | 28,755,073 |
Return
| Return on Equity | 1111.99% |
|---|---|
| Return on Assets | -4668.99% |
| Return on Invested Capital | 199.54% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -2.81 |
| Debt to Equity | -0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.80
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.20%▼ 578.15% |
|---|---|
| Total Invested | $22▼ 99.94% |
| Investors Holding | 1▼ 21.00% |
ESG Score
No data